Previous studies suggested that NCAPG was significantly up-regulated in a variety of malignant solid tumors including liver cancer, prostate cancer, gastric cancer, renal clear cell carcinoma, etc [2,18–21]. The gene discussed is NCAPG; the disease is liver cancer.